Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00597090 · ClinicalTrials.gov registry record
The Role of Genetic Polymorphisms in Innate Immune Response Genes in Susceptibility to Infections
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 319
- Enrollment target
NCT00597090: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00597090 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 319 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00597090 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 319 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand genetic susceptibility to infections and the interactions of specific genetic polymorphisms of innate immune receptors with microbial and fungal organisms. The goals of this study are: 1. Find out if some people are more likely to get severe infections, than others. To do this we will compare patients with leukemia who develop severe infections to patients who do not develop infections. 2. Find out if some people are more likely to develop lymphoma than others. To do this we will compare patients with lymphoma to people without lymphoma who are of the same sex and similar age and ethnic background to the patients with lymphoma.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 319 participants |
| Start Date | 2003-02 |
| Est. Completion | 2011-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00597090
The ClinicalTrials.gov registry entry for NCT00597090 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 319 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00597090 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00597090 about?
NCT00597090 is a clinical study titled "The Role of Genetic Polymorphisms in Innate Immune Response Genes in Susceptibility to Infections". The purpose of this study is to better understand genetic susceptibility to infections and the interactions of specific genetic polymorphisms of innate immune receptors with microbial and fungal organisms. The goals of this study are: 1. Find out if some people are more likely to get severe infect...
What is the current status of trial NCT00597090?
This trial is currently completed. The enrollment target is 319 participants. The study started on 2003-02. Estimated completion is 2011-01.
Who is sponsoring clinical trial NCT00597090?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.